Inventor · disambiguated record
Mark Marchionni
Also filed as: MARCHIONNI MARK · MARCHIONNI MARK A · MARCHIONNI MARK ANDREW
24 granted patents·4 pending applications·578 citations·filing 1992–2020
97Inventor score
Files withACORDA THERAPEUTICS INC14CAMBRIDGE NEUROSCIENCE INC4MARCHIONNI MARK4CENES PHARMACEUTICALS INC2ACORDA THERAPEUTICS1
Top patents by PatentIndex Score
28 records- 0196US8114838B2Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2MARCHIONNI MARK·Filed 2005·Granted Feb 14, 2012·52 cites·6 claims
- 0294US5716930AGlial growth factorsLUDWIG INST CANCER RES·Filed 1994·Granted Feb 10, 1998·109 cites·4 claims
- 0392US6635249B1Methods for treating congestive heart failureCENES PHARMACEUTICALS INC·Filed 1999·Granted Oct 21, 2003·88 cites·19 claims
- 0489US8394761B2Methods for treating congestive heart failureMARCHIONNI MARK·Filed 2011·Granted Mar 12, 2013·12 cites·26 claims
- 0587US6444642B1Methods of increasing myotube formation or survival or muscle cell mitogenesis, differentiation or survival using a neuregulinCENES PHARMACEUTICALS INC·Filed 1995·Granted Sep 3, 2002·53 cites·40 claims
- 0685US8076283B2Methods for treating congestive heart failureMARCHIONNI MARK·Filed 2009·Granted Dec 13, 2011·6 cites·18 claims
- 0783US7662772B2Methods for treating congestive heart failureACORDA THERAPEUTICS INC·Filed 2003·Granted Feb 16, 2010·13 cites·15 claims
- 0881US7037888B1Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 1995·Granted May 2, 2006·60 cites·36 claims
- 0980US8026213B2Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 2010·Granted Sep 27, 2011·3 cites·1 claims
- 1080US6750196B1Methods of treating disorders of the eyeACORDA THERAPEUTICS·Filed 1995·Granted Jun 15, 2004·47 cites·21 claims
- 1179US6087323AUse of neuregulins as modulators of cellular communicationCAMBRIDGE NEUROSCIENCE INC·Filed 1994·Granted Jul 11, 2000·42 cites·20 claims
- 1276US10065999B2Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2ACORDA THERAPEUTICS INC·Filed 2014·Granted Sep 4, 2018·1 cites·6 claims
- 1376US7968678B2Glial mitogenic factors, their preparation and useACORDA THERAPEUTICS INC·Filed 2007·Granted Jun 28, 2011·1 cites·7 claims
- 1475US10717775B2Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2ACORDA THERAPEUTICS INC·Filed 2018·Granted Jul 21, 2020·0 cites·9 claims
- 1575US7718606B2Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 2008·Granted May 18, 2010·1 cites·12 claims
- 1675US6890751B2NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methodsACORDA THERAPEUTICS INC·Filed 2001·Granted May 10, 2005·4 cites·15 claims
- 1774US10232016B2Methods for treating congestive heart failureACORDA THERAPEUTICS INC·Filed 2015·Granted Mar 19, 2019·1 cites·25 claims
- 1874US7115554B1Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF IIIACORDA THERAPEUTICS INC·Filed 1994·Granted Oct 3, 2006·19 cites·35 claims
- 1972US7319019B1Glial mitogenic factors lacking an N-terminal signal sequenceACORDA THERAPEUTICS INC·Filed 1996·Granted Jan 15, 2008·18 cites·9 claims
- 2071US5876973AMethod for making antibodies which specifically bind to glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Mar 2, 1999·28 cites·1 claims
- 2171US2020354422A1Methods for cardiomyocyte survival, proliferation or differentiation by nrg-2ACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2265US7384756B1Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 1995·Granted Jun 10, 2008·14 cites·26 claims
- 2363US6872698B2Methods for treating neurological injuries and disordersSCION PHARMACEUTICALS INC·Filed 2001·Granted Mar 29, 2005·2 cites·5 claims
- 2460US2013040879A1Methods For Treating Congestive Heart FailureACORDA THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2559US2012214737A1Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2MARCHIONNI MARK·Filed 2012·Application pending·0 cites
- 2636US6232061B1Homology cloningCAMBRIDGE NEUROSCIENCE INC·Filed 1992·Granted May 15, 2001·3 cites·39 claims
- 2735US6204241B1Method for treating nervous system pathophysiologies using glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Mar 20, 2001·1 cites·21 claims
- 2829US2003040465A1Neuregulins as modulators of cellular communicationFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →